Header Logo

Connection

BRANT WANG to Cystadenocarcinoma, Papillary

Back to Details
This is a "connection" page, showing publications BRANT WANG has written about Cystadenocarcinoma, Papillary.
BRANT WANG
Connection Strength
0.052
Cystadenocarcinoma, Papillary
  1. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003 Mar 19; 95(6):484-6.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.